Drug Trial Radar · NCT05283395
Rocklatan® Evaluation
Last checked: Nov 20, 2026Latest source record: Apr 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Mar 28, 2022
Primary completion
Mar 22, 2023
Study completion Mar 22, 2023
Sponsor
- Lead sponsor
- Aerie PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 17, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the IOP-lowering effect when subjects are switched from various latanoprost-based regimens to Rocklatan. Subjects will stop their IOP-lowering medical therapy regimen and dose with Rocklatan for the duration of the study (12 weeks).
Conditions
- Glaucoma
Interventions
Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solutionDrug
Commercially available ophthalmic solution indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change From Baseline in Intraocular Pressure (IOP) at Week 12Time frame: Baseline (Day 0 pretreatment), Week 12
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
North Valley Eye Medical Group
Mission Hills, California
Visionary Eye Institute
Newport Beach, California
California Eye Specialists Medical Group
Pasadena, California
North Bay Eye Associates
Petaluma, California
Shettle Eye Research
Largo, Florida
Center For Sight
Venice, Florida
Georgia Eye Partners
Atlanta, Georgia
Coastal Research Associates LLC
Roswell, Georgia
Tekwani Vision Center
St Louis, Missouri
OCLI Vision
Manhasset, New York
Mark J. Weiss, MD, Inc.
Tulsa, Oklahoma
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania
Advancing Vision Research
Goodlettsville, Tennessee
VRF Eye Specialty Group
Memphis, Tennessee
Total Eye Care, PA
Memphis, Tennessee
Keystone Research
Austin, Texas
Louis M. Alpern, M.D., M.P.H., P.A
El Paso, Texas
Houston Eye Associates
Houston, Texas
Emerson Clinical Research Institute
Falls Church, Virginia
Vistar Eye Center
Roanoke, Virginia
The Eye Centers of Racine and Kenosha
Racine, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.